News & Press Releases

CELLERANT APPOINTS RODNEY YOUNG AS CHIEF FINANCIAL OFFICER
June 16, 2015

CELLERANT ANNOUNCES DOSING OF FIRST PATIENT IN RANDOMIZED PHASE 2 CLINICAL TRIAL OF CLT-008 IN ACUTE MYELOID LEUKEMIA PATIENTS
March 17, 2015

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.